Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oncimmune (ONC)

Price 15.35p on 26-11-2024 at 17:30:00
Change 0.00p 0%
Buy 15.70p
Sell 15.00p
Buy / Sell ONC Shares
Last Trade: Sell 2,311.00 at 15.156p
Day's Volume: 37,411
Last Close: 15.35p
Open: 15.35p
ISIN: GB00BYQ94H38
Day's Range 0.00p - 0.00p
52wk Range: 9.35p - 30.20p
Market Capitalisation: £17m
VWAP: 15.79546p
Shares in Issue: 112m

Recent Trades History Oncimmune (ONC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,311 15.156p Ordinary
15:48:28 - 26-Nov-24
Buy* 35,000 15.8396p Ordinary
10:48:26 - 26-Nov-24
Sell* 100 15.124p Ordinary
08:34:19 - 26-Nov-24

Share Price History for Oncimmune

Time period:
to
Date Open High Low Close Volume

Share News for Oncimmune

UK shareholder meetings calendar - next 7 days

1st Nov 2024 13:31

Read More

Oncimmune Holdings shares tick up as notes new contracts

31st Oct 2024 14:09

(Alliance News) - Oncimmune Holdings PLC on Thursday highlighted its ability to secure repeat business from "top 10 pharma companies". Read More

UPDATE: Oncimmune raises GBP2.2 million in equity as planned

21st Oct 2024 12:30

Oncimmune Holdings PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Raises GBP2.2 million from placing of 12.0 million new shares and subscription for 2.3 million more, all at 15 pence. The results of the placing, run as an accelerated bookbuild by brokers Cavendish and Zeus, is in line with plans set out early Friday. Oncimmune also plans a retail share offer of up to 2.0 million shares to raise an additional GBP300,000. Read More

IN BRIEF: Oncimmune converts debt and offers shares in growth push

18th Oct 2024 12:44

Oncimmune Holdings PLC - Nottingham, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Recapitalises two-thirds of its debt and launches a new share offer to raise funds to support recent contract wins and prepare for its "next stage of growth". Read More

Oncimmune expects "substantial" revenue growth following contract wins

9th Sep 2024 11:42

(Alliance News) - Oncimmune Holdings PLC said on Monday that it has entered into five new contracts since its last update in May this year, which are set to substantially grow revenue for financial 2025. Read More

FTSE 100 Latest
Value8,258.61
Change-33.07

Login to your account

Forgot Password?

Not Registered